Generalised tonic-clonic seizure

3 trials 2 recruiting MedDRA PT
3 Registered trials
2 Recruiting
2 Unique sponsors
2 Unique IMPs
3 Commercial trials
Drug classes (ATC)
— ATC code not specified 2
N Neurology/Psychiatry (ATC N) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Phase III: 3

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase III

3 trials
  • Sk Life Science Inc. Commercial
    CENOBAMATE
    2023-506687-13-00 5 countries 2019 n=84
    Ended
  • Sk Life Science Inc. Commercial
    CENOBAMATE
    2023-506688-32-00 5 countries 2019 n=77
    Recruiting
  • Xenon Pharmaceuticals Inc. Commercial
    AZETUKALNER
    2022-502286-16-00 12 countries 2023 n=106
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Sk Life Science Inc. Commercial 2 Phase III 1
Xenon Pharmaceuticals Inc. Commercial 1 Phase III 1
New trials by year
2019
2
2023
1
← All indication landscapes